These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


125 related items for PubMed ID: 7947054

  • 1. Onset of leukaemia after levamisole treatment for nephrotic syndrome.
    Mackie FE, Roy LP, Stevens M.
    Pediatr Nephrol; 1994 Aug; 8(4):527-8. PubMed ID: 7947054
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of idiopathic nephrotic syndrome with levamisole.
    Niaudet P, Drachman R, Gagnadoux MF, Broyer M.
    Acta Paediatr Scand; 1984 Sep; 73(5):637-41. PubMed ID: 6385610
    [Abstract] [Full Text] [Related]

  • 3. Disseminated autoimmune disease during levamisole treatment of nephrotic syndrome.
    Barbano G, Ginevri F, Ghiggeri GM, Gusmano R.
    Pediatr Nephrol; 1999 Sep; 13(7):602-3. PubMed ID: 10460511
    [Abstract] [Full Text] [Related]

  • 4. Side effects of levamisole in children with nephrosis.
    Palcoux JB, Niaudet P, Goumy P.
    Pediatr Nephrol; 1994 Apr; 8(2):263-4. PubMed ID: 8018513
    [No Abstract] [Full Text] [Related]

  • 5. [Levamisole in children with frequently recurring idiopathic nephrotic syndrome].
    Meregalli P, Bianchetti MG, Imoberdorf G, Lütschg J, Reymond D, Oetliker OH.
    Schweiz Med Wochenschr; 1994 May 14; 124(19):801-5. PubMed ID: 8209202
    [Abstract] [Full Text] [Related]

  • 6. A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.
    Gruppen MP, Bouts AH, Jansen-van der Weide MC, Merkus MP, Zurowska A, Maternik M, Massella L, Emma F, Niaudet P, Cornelissen EAM, Schurmans T, Raes A, van de Walle J, van Dyck M, Gulati A, Bagga A, Davin JC, all members of the Levamisole Study Group.
    Kidney Int; 2018 Feb 14; 93(2):510-518. PubMed ID: 29054532
    [Abstract] [Full Text] [Related]

  • 7. [Evaluation of the efficacy of levamisole in corticosteroid-dependent nephrotic syndrome in children].
    Ksiazek J, Kryński J.
    Pediatr Pol; 1995 Dec 14; 70(12):1037-42. PubMed ID: 8649943
    [Abstract] [Full Text] [Related]

  • 8. [Levamisole in the treatment of nephrotic syndrome].
    García Soto L, Miranda Romera P, Vintimilla Andrade JE, Gómez Llorente MA, de Diego Fernández P.
    An Pediatr (Engl Ed); 2020 Mar 14; 92(3):168-169. PubMed ID: 31151760
    [No Abstract] [Full Text] [Related]

  • 9. Treatment of nephrotic syndrome with levamisole.
    Tanphaichitr P, Tanphaichitr D, Sureeratanan J, Chatasingh S.
    J Pediatr; 1980 Mar 14; 96(3 Pt 1):490-3. PubMed ID: 6965715
    [Abstract] [Full Text] [Related]

  • 10. Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report.
    Anjum MF, Gupta GK, Bhandari J.
    JNMA J Nepal Med Assoc; 2024 Jul 31; 62(276):545-547. PubMed ID: 39369404
    [Abstract] [Full Text] [Related]

  • 11. Levamisole in steroid-sensitive nephrotic syndrome children with frequent relapses and/or steroid dependency: comparison of daily and every-other-day usage.
    Fu LS, Shien CY, Chi CS.
    Nephron Clin Pract; 2004 Jul 31; 97(4):c137-41. PubMed ID: 15331936
    [Abstract] [Full Text] [Related]

  • 12. Levamisole in children's idiopathic nephrotic syndrome.
    La Manna A, Polito C, Del Gado R, Foglia AC.
    Child Nephrol Urol; 2004 Jul 31; 9(4):200-2. PubMed ID: 3255483
    [Abstract] [Full Text] [Related]

  • 13. Effect of levamisole in steroid-dependent nephrotic syndrome.
    Madani A, Isfahani ST, Rahimzadeh N, Fereshtehnejad SM, Hoseini R, Moghtaderi M, Mohseni P, Ataiee N.
    Iran J Kidney Dis; 2010 Oct 31; 4(4):292-6. PubMed ID: 20852369
    [Abstract] [Full Text] [Related]

  • 14. Distinctive vasculopathy with systemic involvement due to levamisole long-term therapy: a case report.
    Aoun B, Alali M, Degheili JA, Sanjad S, Vaquin C, Donadieu J, Ulinski T, Termos S.
    J Med Case Rep; 2018 Jul 16; 12(1):209. PubMed ID: 30008268
    [Abstract] [Full Text] [Related]

  • 15. Liver toxicity in a nephrotic patient treated with levamisole.
    Bulugahapitiya DT.
    Arch Dis Child; 1997 Mar 16; 76(3):289. PubMed ID: 9135277
    [No Abstract] [Full Text] [Related]

  • 16. Levamisole in steroid-sensitive nephrotic syndrome children with steroid-dependency and/or frequent relapses.
    Fu LS, Chi CS.
    Acta Paediatr Taiwan; 2000 Mar 16; 41(2):80-4. PubMed ID: 10927944
    [Abstract] [Full Text] [Related]

  • 17. Levamisole in steroid-sensitive nephrotic syndrome: usefulness in adult patients and laboratory insights into mechanisms of action via direct action on the kidney podocyte.
    Jiang L, Dasgupta I, Hurcombe JA, Colyer HF, Mathieson PW, Welsh GI.
    Clin Sci (Lond); 2015 Jun 16; 128(12):883-93. PubMed ID: 25626449
    [Abstract] [Full Text] [Related]

  • 18. Treatment of partially corticosteroid-sensitive nephrotic syndrome with levamisole.
    Mancini ML, Rinaldi S, Rizzoni G.
    Pediatr Nephrol; 1994 Dec 16; 8(6):788. PubMed ID: 7696130
    [No Abstract] [Full Text] [Related]

  • 19. Levamisole for childhood nephrotic syndrome.
    Lancet; 1991 Jun 29; 337(8757):1574. PubMed ID: 1675714
    [No Abstract] [Full Text] [Related]

  • 20. Use of levamisole in maintaining remission in steroid-sensitive nephrotic syndrome in children.
    Dayal U, Dayal AK, Shastry JC, Raghupathy P.
    Nephron; 1994 Jun 29; 66(4):408-12. PubMed ID: 8015643
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.